NLCAHR

LINK TO THE REPORT BY CADTH: https://www.cadth.ca/dialysis-modalities-treatment-end-stage-kidney-disease

CADTH’s report notes that home-based hemodialysis is, whether hemodialysis or peritoneal dialysis, both cost effective and clinically effective and that it is generally well-liked by patients.  The report indicates that jurisdictions across Canada should follow NL’s lead on this issue.

Quotes:

• Key Message: “For patients diagnosed with end-stage kidney disease (ESKD) deemed eligible for home therapies by their care provider, self-care home-based dialysis either with home hemodialysis (HD) or peritoneal dialysis (PD) is recommended.”
• Bottom Line: “Overall, home-based modalities appear to offer clinical benefits that are similar to those of [In-Centre HemoDialysis (ICHD)]. No consistent differences in patient health-related QoL outcomes were identified between [Home HemoDialysis (HHD)] and ICHD or between [Peritoneal Dialysis (PD)] and ICHD. There is no clear evidence of a survival benefit with any specific dialysis modality.”
• The NL Example: “In all provinces, HD remains the modality most frequently used for new patients who require dialysis, with Newfoundland and Labrador having the greatest proportion of ESKD patients initiated on HD (91%) in 2013. Moreover, for the same year, most Canadian dialysis patients (76%) received in-centre HD (ICHD), which describes HD performed in an institution such as a hospital, satellite unit, or a dialysis facility with the assistance of a health care professional.”

If you are interested, there will be a Webinar on this topic on November 9^th, hosted by CADTH-  Register here by November 7, 2017

https://www.cadth.ca/events/special-event-home-based-dialysis-canada-evidence-practice